intranasal dose

Related by string. intranasal doses * intra nasal . Intranasal : live attenuated intranasal . intranasal corticosteroid . intranasal ketamine . Intranasal Ketamine . intranasal oxytocin . intranasal corticosteroids / DO Se . Doses . DOSE . DOSES . doses . Dose : mg kg dose . label dose escalation . tolerated dose MTD . dose escalation study . multiple ascending dose . priming doses * *

Related by context. Frequent words. (Click for all words.) 58 intramuscularly 54 ascending doses 53 μg kg 52 subcutaneous injections 51 Traficet EN 50 orally bioavailable 49 serum concentrations 49 dose titration 48 #mg/kg [002] 48 mg QD 48 dose cohorts 48 PRECiSE 48 conjugates 48 mg kg dose 48 Solid Tumors 47 RRMS patients 46 xenograft models 46 NRTI 46 humanized antibody 46 mg dose 46 mg d 46 enfuvirtide 46 CG# [001] 46 nucleoside reverse transcriptase inhibitors 45 darunavir 45 PRX# 45 dose regimens 45 BNC# 45 pharmacokinetic profiles 45 etoposide 45 tipranavir 45 NNRTIs 45 IFN alpha 45 pharmacodynamics 44 ULN 44 chemotherapeutic drug 44 tumor antigen 44 mg BID 44 citalopram 44 phenotyping 44 kinase inhibitor 44 ATL# [001] 44 CI -#.# 43 poxvirus 43 GV# [001] 43 synthetic peptides 43 inactive placebo 43 virologic 43 Maraviroc 43 PK PD 43 patients evaluable 43 placebo controlled clinical trials 42 genotypic 42 placebo p = 42 MAb 42 raltegravir 42 Cmax 42 seliciclib 42 pharmacodynamic 41 DB# [003] 41 etravirine 41 retinoid 41 nucleoside 41 anticholinergics 41 PREZISTA r 41 blinded placebo controlled 40 NRTIs 40 DMARD 40 IMC A# 40 HBV DNA 40 randomized #:# 40 NSABP 40 RCTs 40 INTELENCE 39 prespecified 39 pharmacokinetics 39 evaluable patients 39 n = 39 maraviroc 39 evaluable 39 Pharmacokinetic 39 myeloproliferative disorders 39 vicriviroc 39 ISENTRESS 39 ziprasidone 39 protease inhibitor 39 RTOG 38 haematological 38 Mice 38 liver transplant recipients 38 demonstrated statistically significant 38 Secondary endpoints included 38 lacosamide 38 P = .# 38 statistically significant improvement 38 PsA 38 laboratory abnormalities 38 metabolomic 38 chromatographic 38 kinase inhibitors 38 Concomitant

Back to home page